Avedro, Inc.

Avedro, Inc.

Avedro, Inc.

Overview
Date Founded

2002

Headquarters

201 Jones Road, Waltham, MA, 02451, USA

Type of Company

Private

Employees (Worldwide)

101 - 250

Industries

Medical Products & Equipment
Hospitals & Patient Services
Pharmaceuticals

Company Description

Avedro, Inc. develops ophthalmic medical devices and pharmaceutical products. The firm’s products include KXL System, Mosaic system, IROC system and Riboflavin family. Its procedure includes Lasic Xtra, accelerated cross-linking and photorefractive intrastromal cross-linking. The company was founded by David F. Muller and B. Stuart Trembly on November 6, 2002 and is headquartered in Waltham, MA.

Contact Data
Trying to get in touch with decision makers at Avedro, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Chief Medical Officer

Director, Chief Financial Officer & Senior Vice President, Corporate Development

Vice President, Health Policy & Market Access

General Manager

Controller

Director of Marketing

Talent Coordinator for Matt Logan (Vice President of Cwm)

Vice President

Vice President-Operation

Vice President-Sales

Paths to Avedro, Inc.
Potential Connections via
Relationship Science
You
Avedro, Inc.
Recent Transactions
Details Hidden

Glaukos Corp. purchases Avedro, Inc.

Details Hidden

Avedro, Inc. issued USD Common Stock

Details Hidden

Avedro, Inc. raised money in a private placement transaction

Transaction Advisors
Legal Advisor

Advised onGlaukos Corp. purchases Avedro, Inc.

Investment Advisor

Advised onGlaukos Corp. purchases Avedro, Inc.

Underwriter

Advised onAvedro, Inc. issued USD Common Stock

Legal Advisor

Advised onGlaukos Corp. purchases Avedro, Inc.

Associate

Advised onAvedro, Inc. issued USD Common Stock

Associate

Advised onAvedro, Inc. issued USD Common Stock

Advisors & Consultants
Legal Advisor

Partner, Boston at Cooley LLP

Advisor

Partner, Tenant Advisory-Office, Agency Leasing-Office at Transwestern RBJ LLC

Key Stats and Financials As of 2018
Market Capitalization
$406M
Total Enterprise Value
Earnings Per Share
Revenue
$27.7M
EBITDA
$-20.6M
Non-Profit Donations & Grants
Investors
Details Hidden

InterWest Partners focuses on early-stage investments in life sciences and information technology companies. Within the life sciences sector, the firm invests in a range of early-stage opportunities including the funding of preclinical companies with great potential. They also consider investing in or starting new companies around clinical or commercial stage assets. Within the information technology sector, InterWest looks for early-stage companies with near-term ROI-based value propositions. They favor investments in development-stage companies. Investments average $10 million to $15 million over the life of a company. InterWest serves as the lead investor in the majority of their investments.

Details Hidden

Former Non-Executive Chairman & Chief Executive Officer at Nautilus, Inc.

Details Hidden

LAV is an active manager which invests in seed-stage and listed and unlisted companies. The firm targets companies operating in the biopharmaceuticals sector, human therapeutics, medical devices, and diagnostics industries.It invests in young companies located in China and the United States.

Suppliers
Albany Molecular Research, Inc. Holding Companies | Albany, New York

Albany Molecular Research, Inc. operates as a contract research and manufacturing organization. It offers drug delivery, drug development, analytical services, API development and manufacturing , and drug product solutions. The company was founded by Thomas E. D'Ambra on June 19, 1991 and is headquartered in Albany, NY.

Ajinomoto Co., Inc. Food | Tokyo, Japan

Ajinomoto Co., Inc. engages in the manufacture, distribution, and sale of food products, amino acids, and pharmaceuticals. It operates through the following segments: Domestic Food Products, Overseas Food Products, Life Support, Healthcare and Others. The Domestic Food Products segment includes seasonings and processed foods, and frozen foods. The Overseas Food Products segment provides consumer foods, which include flavor seasonings and instant noodles; and umami seasonings for processed food manufacturers. The Life Support segment offers feed-use amino acids, amino acids for pharmaceuticals and foods, sweeteners, pharmaceutical fine chemicals, and specialty chemicals. The Healthcare segment handles medical foods and pharmaceuticals. The Others segment covers the packaging materials business, healthcare business, partnership business, logistics, and other services. The company was founded by Saburosuke Suzuki II on May 20, 1909 and is headquartered in Tokyo, Japan.

California Institute of Technology Investment Services & Portfolio Management | Pasadena,

California Institute of Technology provides education focusing on science, engineering, academia, business, and public service. The company was founded in 1891 and it is headquartered in Pasadena, CA.

Competitors
AbbVie, Inc. Pharmaceuticals - North Chicago, IL

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the discovery, development, manufacture and sale of a line of proprietary pharmaceutical products. It is focused on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C and human immunodeficiency virus; neurological disorders, such as Parkinson's disease; metabolic diseases, including thyroid disease and complications associated with cystic fibrosis; as well as other serious health conditions. The company was founded on 2013 and is headquartered in North Chicago, IL.

Novartis AG Pharmaceuticals - Basel, Switzerland

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Clerio Vision, Inc. Hospitals & Patient Services - West Henrietta, NY

Clerio Vision, Inc. develops noninvasive refractive vision correction technology. The company was founded by J. Mikael Totterman, Alex Zapesochny, and Alexandra Latypova, Scott Catlin in 2014 and is headquartered in Rochester, NY.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Avedro, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Avedro, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Avedro, Inc..